Annals of Nuclear Medicine

Papers
(The TQCC of Annals of Nuclear Medicine is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)
ArticleCitations
Assessing dedicated breast PET performance in breast cancer screening alongside digital mammography, digital breast tomosynthesis, and ultrasound: a reader's insight48
Clinical perspective on targeted alpha therapy using 225Ac44
Comment on “Subcutaneous/cutaneous uptake in the cancer-affected breast on 18F-FDG PET/CT: association with post-surgical prognosis in breast cancer”39
Correction: Novel indices representing heterogeneous distributions of myocardial perfusion imaging31
A first-in-man study of [18F] FEDAC: a novel PET tracer for the 18-kDa translocator protein30
Utility of serum blood ketone levels and other risk factors for inadequate myocardial glucose suppression ketogenic FDG-PET/CT: a prospective and retrospective cohort study27
Adenosine FDG PET/CT reveals potentially viable myocardium in ischemic cardiomyopathy26
Integrating functional and volumetric assessments in 90Y radioembolization: added value of [⁹⁹ᵐTc]Mebrofenin scintigraphy24
18F-FET PET/CT can aid in diagnosing patients with indeterminate MRI findings for brain tumors: a prospective study24
A first-in-man PET study of 2-amino-[3-11C] isobutyric acid for the amino acid transport System A: biodistribution and dosimetry in healthy volunteers21
Vision-language model performance on the Japanese Nuclear Medicine Board Examination: high accuracy in text but challenges with image interpretation19
Research trends and hotspots of radioiodine-refractory thyroid cancer treatment in the twenty-first century: a bibliometric analysis19
Semiquantitative analysis using whole-body dynamic F-18 fluoro-2-deoxy-glucose–positron emission tomography to differentiate between benign and malignant lesions19
FAPI radiopharmaceuticals in nuclear oncology and theranostics of solid tumours: are we nearer to surrounding the hallmarks of cancer?17
Correction: Locoregional indicators of systemic spread in breast cancer: insights from standard-of-care imaging and ¹⁸F-FDG PET/CT17
Comparison of automated bone scan indexes in patients with prostate cancer: aBSI and BONENAVI17
Highly specific amyloid and tau PET ligands for ATN classification in suspected Alzheimer’s disease patients16
Non-metastatic castration-resistant prostate cancer in the epoch of PSMA-ligand PET/CT: twilight?16
[18F]FDG PET/CT is useful in discriminating invasive adenocarcinomas among pure ground-glass nodules: comparison with CT findings—a bicenter retrospective study15
Impact of irregular waveforms on data-driven respiratory gated PET/CT images processed using MotionFree algorithm14
J-ACCESS investigation and nuclear cardiology in Japan: implications for heart failure14
Increase of prostate-specific antigen doubling time predicts survival in metastatic castration-resistant prostate cancer patients undergoing radium therapy14
Correction: Practice recommendation for measuring washout rates in 123I-BMIPP fatty acid images13
Comparison of the diagnostic accuracy of VSBONE BSI versions for detecting bone metastases in breast and prostate carcinoma patients using conventional and CZT detector gamma cameras13
Limitations of an (18)F-FDG PET/CT radiomic nomogram for predicting axillary response in breast cancer13
A fully automatic deep learning-based method for segmenting regions of interest and predicting renal function in pediatric dynamic renal scintigraphy13
Incidence of renal scarring on technetium-99 m dimercaptosuccinic acid renal scintigraphy after acute pyelonephritis, acute focal bacterial nephritis, and renal abscess12
Diagnostic accuracy of artificial intelligence-assisted 18f-fdg pet/ct for predicting pathological complete response to neoadjuvant chemotherapy in breast cancer: a systematic review and meta-analysis12
The value of 18F-FDG PET/CT in Langerhans cell histiocytosis12
Methyl-11C-L-methionine positron emission tomography for radiotherapy planning for recurrent malignant glioma12
Prognostic value of pre-treatment metabolic tumor volume on [S‑methyl‑11C]‑L‑methionine PET/CT in patients with local non-small cell lung carcinoma treated with single-fraction carbon-ion radiotherapy12
Correction: Clinical assessment and striatal dopaminergic activity in healthy controls and patients with Parkinson’s disease: a Bayesian approach12
Patterns of positron emission mammography uptake by benign and malignant breast lesions: radiopathological correlation with malignant histopathological subtypes, histological grades, and molecular sub11
Prognostic value of integrated FDG PET/CT avidity and CT morphologic subtypes in invasive mucinous adenocarcinoma of the lung11
Target-anchored platform concentration and uneven developmental consolidation in systemic solid-tumor radioligand therapy: a retrospective Trialtrove-based analysis11
Impact of posture change on patient-specific absorbed dose estimation in nuclear medicine10
Registration accuracy of amyloid/tau-PET to brain MRI using modified SPM method10
Letter to the editor: [18F]SMBT-1 PET quantification – methodological considerations and future directions10
PETFormer-SCL: a supervised contrastive learning-guided CNN–transformer hybrid network for Parkinsonism classification from FDG-PET10
Efficacy of [68Ga]Ga-FAPI-PET as a non-invasive evaluation method of liver fibrosis10
Diagnostic value of 18F-FDG PET/CT in the follow-up of conjunctival melanoma9
Simultaneous evaluation of brain metastasis and thoracic cancer using semiconductor 11C-methionine PET/CT imaging9
Quantitative Imaging Evaluation of Structural and Densitometric Changes in Major Salivary Glands After 177Lu PSMA Radioligand Therapy9
Feasibility of whole-body 2-deoxy-2-[18F]fluoro-d-glucose positron emission tomography angiography using continuous bed motion in patients with vascular disease: a pilot study9
Effect of previous 177Lu-DOTATATE treatment on 90Y-microsphere treatment response in neuroendocrine tumor patients with liver metastasis9
Novel indices representing heterogeneous distributions of myocardial perfusion imaging9
Insights into lung cancer diagnosis and clinical management using [18F]F-fibroblast activation protein inhibitor (FAPI)-42 positron emission tomography/computed tomography (PET/CT)9
Diagnostic value of FDG PET/CT in determining the etiology of pericardial effusion8
Recent advancements in new tracers from first-in-human studies8
Differential centiloid scale normalization techniques: comparison between hybrid PET/MRI and independently acquired MRI8
Can interactive artificial intelligence be used for patient explanations of nuclear medicine examinations in Japanese?8
Improvement in the estimation of perfusable tissue fraction and myocardial flow reserve in the ischemic myocardial lesions using ECG-gated dynamic myocardial PET with 15O-water8
Flare phenomenon visualized by 99mTc-bone scintigraphy has prognostic value for patients with metastatic castration-resistant prostate cancer8
Increased individual workload for nuclear medicine physicians over the past years: 2008–2023 data from The Netherlands8
Factors predicting remission in hyperthyroid patients after low-dose I-131 therapy: 20 years retrospective study from a tertiary care hospital8
A Monte Carlo study comparing dead-time losses of a gamma camera between tungsten functional paper and lead sheet for dosimetry in targeted radionuclide therapy with Lu-1777
Prognostic value of textural features obtained from F-fluorodeoxyglucose (F-18 FDG) positron emission tomography/computed tomography (PET/CT) in patients with locally advanced cervical cancer undergoi7
Is there any effect of hcc location on selective internal radiation therapy with 90yttrium response?7
[11C]-Methionine PET/CT in evaluation of bone marrow infiltration and usage as a prognostic tool in multiple myeloma7
[99mTc]-labeling and evaluation of a new linear peptide for imaging of glioblastoma as a αvβ3-positive tumor7
High efficacy of particle beam therapies against tumors under hypoxia and prediction of the early stage treatment effect using 3'-deoxy-3'-[18F]fluorothymidine positron emission tomography7
Reply to the letter regarding “Long-term efficacy and safety of peptide receptor radionuclide therapy in Japanese patients with unresectable neuroendocrine tumor: extension of the Japanese phase I and7
18F-FDG PET/CT manifestations of extra-adrenal retroperitoneal ganglioneuroma: a retrospective study of 21 cases7
Current status and perspectives of nuclear cardiology7
Correction: Diagnostic utility and characteristics of CT-based attenuation correction in brain perfusion SPECT/CT in predicting the exacerbation of Alzheimer changes from mild cognitive impairment uti7
Multimodal imaging analysis of autosomal recessive Parkinson’s disease7
SPECT reconstruction using preprocessing masking for extra-cardiac uptake versus standard processing in 99mTc-sestamibi myocardial perfusion imaging7
Correction: Subcutaneous/cutaneous uptake in the cancer-affected breast on 18F-FDG PET/CT: association with post-surgical prognosis in breast cancer patients7
Is It time to move beyond FDG toward a more specific yet broadly applicable radiotracer such as FAPI? why yes—and why not6
Semi-quantitative tau PET approaches for Braak staging: concordance of CenTauRz and STOC with visual assessment6
Next day sentinel node biopsy for melanoma after lymphoscintigraphy using 99mTc-labelled nanocolloid does not adversely affect long-term outcomes6
The value of net influx constant based on FDG PET/CT dynamic imaging in the differential diagnosis of metastatic from non-metastatic lymph nodes in lung cancer6
Quantitative SPECT imaging for predicting therapeutic response to lutetium-177 DOTATATE in neuroendocrine tumors6
Response to the comment on “[11C]-Methionine PET/CT in evaluation of bone marrow infiltration and usage as a prognostic tool in multiple myeloma”6
Adsorption treatment of 177Lu radioactive wastewater with 177mLu impurity: batch versus column methods6
Assessment of post-pyeloplasty renal drainage in antenatally detected hydronephrosis by 99mTc-L, L-Ethylenedicysteine renal scintigraphy: the importance of delayed imaging6
Fundamental evaluation regarding the relationship between albumin-binding and tumor accumulation of PSMA-targeting radioligands6
Brain imaging of sequential acquisition using a flexible PET scanner and 3-T MRI: quantitative and qualitative assessment6
Impact of preoperative [18F]FDG PET/CT vs. contrast-enhanced CT in the staging and survival of patients with clinical stage I and II non-small cell lung cancer: a 10-year follow-up study6
Detection of apoptosis by [18F]ML-10 after cardiac ischemia–reperfusion injury in mice6
Are [18F]FDG PET/CT imaging and cell blood count-derived biomarkers robust non-invasive surrogates for tumor-infiltrating lymphocytes in early-stage breast cancer?6
Validation of advanced hybrid SPECT/CT system using dynamic anthropomorphic cardiac phantom6
Physiological bio-distribution of 68Ga-DOTA-TATE in pediatric patients5
Effects of apitherapy against salivary gland disorder after radioactive iodine therapy for differentiated thyroid cancer5
Differential performance of statistical versus machine learning methods in partial volume correction in oncologic F18-FDG PET/CT scanning5
Booster administration of Tc-99m PMT for delayed static imaging in patients with biliary atresia5
Blood and bone marrow dosimetry for thyroid cancer patients prepared with rhTSH injection5
Assessment of environmental radioactive contamination in radiation therapy rooms: comparison between therapy after Lu-177 DOTATATE and I-1315
Comparative evaluation of radionuclide therapy using 90Y and 177Lu5
Radiation dosimetry and pharmacokinetics of the tau PET tracer florzolotau (18F) in healthy Japanese subjects5
New objective simple evaluation methods of amyloid PET/CT using whole-brain histogram and Top20%-Map5
Comments on Association between technetium-99 m albumin scintigraphy-based severity of protein-losing enteropathy and patient characteristics and laboratory data5
Diagnostic performance of F-18 FDG PET/CT in differentiating autoimmune pancreatitis from pancreatic cancer: a systemic review and meta-analysis5
Establishment of National Diagnostic Reference Levels 2025 for nuclear medicine in Japan5
Convolutional neural network-based program to predict lymph node metastasis of non-small cell lung cancer using 18F-FDG PET5
Comparison of image quality of breast-specific positron emission tomography between opposite-type and ring-shaped systems: insights from Phantom and clinical studies in a Japanese multicenter trial5
Protein expression of glucose metabolism and somatostatin receptor between primary tumor and distant metastasis in differentiated thyroid cancer5
Feasibility of position emission tomography derived endocardial wall strain: direct comparison with magnetic resonance using hybrid 13N ammonia PETMR system5
Recent topics in fibroblast activation protein inhibitor-PET/CT: clinical and pharmacological aspects5
Superiority of 68Ga-PSMA-11 PET/CT over mpMRI for lateralization accuracy of diagnosing intra-glandular prostate cancer lesions: avoiding fluke targeting5
Points for clear interpretation of AI-assisted 18 F-FDG PET/CT in breast cancer5
Investigation on low-iodine diet implementation by medical staff before radioactive iodine treatment for differentiated thyroid carcinoma4
SPECT/CT imaging: quantifying 99mTc-MDP concentration in the spine and pelvis4
Predictive value of 18F-FDG PET/CT-based radiomics model for lymph node metastasis in esophageal squamous cell carcinoma4
Preoperative diagnostic accuracy of thyroid follicular carcinoma using fluorine-18-fluorodeoxyglucose-positron emission tomography/computed tomography and blood data4
No-carrier-added 177Lu production eliminates persistent urine radioactivity: implications for safe expansion of targeted radionuclide therapy4
SPECT and PET imaging of Alzheimer’s disease revisited: from biomarkers to artificial intelligence-based prediction4
Comment on “Long-term efficacy and safety of peptide receptor radionuclide therapy in Japanese patients with unresectable neuroendocrine tumor: extension of the Japanese phase I and phase I/II study”4
Interobserver and intraobserver agreement for equivocal lesions in Ga-68 PSMA PET/CT according to PSMA-RADS 2.0 criteria4
Pre-treatment 111In-pentetreotide SPECT/CT vs. baseline 177Lu-DOTATATE SPECT/CT: are there differences in lesion uptake and detectability?4
Comparative evaluation of CortexID and VIZCalc software in brain amyloid PET: a retrospective study of 116 cases4
The role of dual-tracer PET imaging with ER and HER2 in patients with metastatic breast cancer: a pilot study4
Performance of dedicated breast PET in breast cancer screening: comparison with digital mammography plus digital breast tomosynthesis and ultrasound4
Toward standardization of tau PET imaging corresponding to various tau PET tracers: a multicenter phantom study4
Examination of simple artificial intelligence-based analysis of dopamine transporter scintigraphy for supporting a diagnosis of Parkinson’s disease4
Role of baseline 68Ga-PSMA PET/CT-derived whole-body volumetric parameters in predicting survival outcomes of metastatic castration-resistant prostate cancer patients receiving first-line treatment4
Differentiating second primary lung cancer from pulmonary metastasis in patients of single solitary pulmonary lesion with extrapulmonary tumor using multiparametric analysis of FDG PET/CT4
Deep learning-guided attenuation and scatter correction of 99mTc-MAA SPECT images: towards quantitative analysis in 90Y-SIRT4
Response to “Beyond glucose uptake: rethinking PET/CT and hematologic markers for immune profiling in early breast cancer”4
Correlation between the thyroid computed tomography value and thyroid function in hyperthyroidism: a retrospective study4
The quest for multifunctional and dedicated PET instrumentation with irregular geometries4
Response to the comment on the impact of anti-HER2 therapy on the accuracy of 68 Ga-HER2-affibody PET/CT imaging in metastatic breast cancer4
Advances in the molecular imaging of primary aldosteronism4
New index to assess the extent of bone disease in patients with prostate cancer using SPECT/CT4
Predictive value of 18F-fluorodeoxyglucose uptake for axillary lymph node metastasis in operable breast cancer: impact of molecular subtypes4
Evaluation of 68Ga-PSMA-11 PET/CT: a Phase 1 clinical study in Japanese patients with primary, recurrent, or suspected recurrent prostate cancer4
Comparative post-therapeutic dosimetry between 2D planar-based and hybrid-based methods for personalized Lu-177 treatment4
Clinical significance of suspicious incidental FDG uptake: a comparison between digital PET/CT and conventional PET/CT4
A review of harmonization strategies for quantitative PET4
Accurate CT-free correction of attenuation, scatter, and aperture effects using deep learning in dedicated cardiac pinhole SPECT4
Validation of quantitative [18F]NaF PET uptake parameters in bone diseases: a systematic review4
Diagnostic performance of lung perfusion SPECT/CT using perfusion defect and decrease criteria: a comparative study with CTPA in pulmonary thromboembolism4
Effect of magnetic resonance image-based motion correction on the centiloid scale: a comparison with and without correction4
A prospective study of 68Ga-PSMA PET/CT imaging of HCC as diagnosed on conventional imaging to evaluate for potential 177Lu-PSMA therapy4
Coronary microvascular injury detection and prediction after successful primary percutaneous coronary intervention: non-invasive assessment using single photon emission tomography myocardial perfusion4
Development of lung cancer risk prediction models based on F-18 FDG PET images4
Doughnut-shaped bone lesions on 18F-FDG-PET/CT may indicate pseudoprogression under immuno(radio)therapy4
Role of PSMA-targeted PET-CT in renal cell carcinoma: a systematic review and meta-analysis4
Pharmacokinetics and dosimetry of [177Lu]Lu-PSMA-617 and [68Ga]Ga-PSMA-11 in Japanese patients with PSMA-positive mCRPC4
AI screening of nuclear medicine safety breaches: patterns, causes, and opportunities for improved protocols: a systematic review4
Use of dose–volume histograms for metabolic response prediction in hepatocellular carcinoma patients undergoing transarterial radioembolization with Y-90 resin microspheres4
Clinical impact of amyloid PET using 18F-florbetapir in patients with cognitive impairment and suspected Alzheimer’s disease: a multicenter study4
Radiolabeled florescent-magnetic graphene oxide nanosheets: probing the biodistribution of a potential PET-MRI hybrid imaging agent for detection of fibrosarcoma tumor4
Diagnostic performance of noninvasive imaging using computed tomography, magnetic resonance imaging, and positron emission tomography for the detection of ovarian cancer: a meta-analysis4
0.53421688079834